menu
About Us
Classes Of Business
HMO Reinsurance
Provider Excess Of Less
Medical Reinsurance
Employer Stop Loss
Client Captive Programs
Cell & Gene Therapy
Cost Containment
News
Contact Us
News
Bluebird wins FDA approval of gene therapy for rare brain disorder
on
September 19, 2022
(updated October 18, 2022)
| Category:
News
Bluebird wins FDA approval of gene therapy for rare brain disorder
Click here to download PDF
